Two established techniques for correcting the root cause of the heart rhythm disorder atrial fibrillation show similar effects and safety outcomes, according to research presented at the American College of Cardiology's 65th ...
Apr 4, 2016
A new stem cell therapy significantly improved long-term health outcomes in patients with severe and end-stage heart failure in a study presented at the American College of Cardiology's 65th Annual Scientific Session.
Apr 4, 2016
Patients treated with CMX-2043—an investigational drug that has previously shown some ability to protect heart muscle from damage during stenting—saw no improved protection in their kidneys compared to placebo, according ...
Apr 4, 2016
In one of the largest trials ever conducted in patients who have heart failure with reduced ejection fraction—a measure of the heart's ability to pump blood—the investigational drug aliskiren failed to show superiority ...
Apr 4, 2016
Five of six patients with advanced metastatic urothelial cancer and at least one of two specific genetic abnormalities, responded to treatment with afatinib, which was approved in 2013 by the Food and Drug Administration ...
Apr 4, 2016
In the first large randomized trial to directly compare two approaches to preventing a type of abnormal heart rhythm that is the most common complication of heart surgery, the two strategies—controlling heart rate and controlling ...
Apr 4, 2016
In the final, five-year follow-up report from the influential STAMPEDE trial, Cleveland Clinic research shows that bariatric surgery's beneficial effects on blood glucose control in mild and moderately obese patients with ...
Apr 4, 2016
